Results 61 to 70 of about 600 (104)

Endostatin-based anti-angiogenic therapy and immune modulation: mechanisms and synergistic potential in cancer treatment. [PDF]

Front Immunol
Sun J, Ren S, Zhao Q, He J, Wang Y, Ren M.   +5 more
europepmc   +1 more source

A meta-analysis of recombinant human endostatin combined with NP regimen for treating non-small cell lung cancer. [PDF]

Medicine (Baltimore)
Gao C, Gao C, Yuan Q.
europepmc   +1 more source

Endostatin shows a useful value for predicting failure to recover from acute kidney injury: some confounders to consider. [PDF]

Crit Care, 2020
Honore PM, David C, Mugisha A, Attou R, Redant S, Gallerani A, De Bels D.   +6 more
europepmc   +1 more source

Sintilimab + Nab-PP Combined with Recombinant Human Vascular Endothelial Inhibitor for Locally Advanced/Advanced and Recurrent Metastatic Squamous Non-Small Cell Lung Cancer: Study Protocol for a Single-Arm, Multi-Centre Phase II Clinical Study. [PDF]

Technol Cancer Res Treat
Xu J, Meng M, He S, Wang S, Peng J, Yao B, Li Y, Hu Y, Qian X, Wang T, Ma H, Zhou JG.   +11 more
europepmc   +1 more source

The Treatment Combining Antiangiogenesis with Chemoradiotherapy Impinges on the Peripheral Circulation Vascular Endothelial Cells and Therapeutic Effect in the Patients with Locally Advanced Nasopharyngeal Carcinoma.

Biomed Res Int, 2022
Gong X, Wang L, Wu W, Li Y, Long J, Chen X, Luo X, He Q, Bi T, Li Z, Luomeng Y, Jin F.   +11 more
europepmc   +1 more source

Acute cardiac tamponade after Endostar treatment of non-small cell lung cancer: A case report. [PDF]

Medicine (Baltimore)
Dong W, Wang M, Zhu P, Sun Q, Wu D.
europepmc   +1 more source

A single-center, retrospective study-spring-evaluating the efficacy and safety of recombinant human vascular endothelial inhibitor combined with anti-PD-1 in elderly patients aged 80 and above with NSCLC. [PDF]

Front Immunol
Xing T, Gao Q, Zhu H, Gao J, Yan G.
europepmc   +1 more source

Inhibitory effect of Endostar on HIF-1 with upregulation of MHC-I in lung cancer cells. [PDF]

Cancer Biol Ther
Zhao MZ, Zheng HF, Wang JN, Zhang YM, Wang HJ, Zhao ZW.   +5 more
europepmc   +1 more source

Recent Trends in Medical Management of Endometriosis. [PDF]

J Obstet Gynaecol India
Patel M.
europepmc   +1 more source

Endostatin-expressing endometrial mesenchymal stem cells inhibit angiogenesis in endometriosis through the miRNA-21-5p/TIMP3/PI3K/Akt/mTOR pathway. [PDF]

Stem Cells Transl Med
Cheng Y, Guo Q, Cheng Y, Wang D, Sun L, Liang T, Wang J, Wu H, Peng Z, Zhang G.   +9 more
europepmc   +1 more source